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Abstract
For many traits, males show greater variability than females, with possible implica-
tions for understanding sex differences in health and disease. Here, the ENIGMA
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(Enhancing Neuro Imaging Genetics through Meta-Analysis) Consortium presents the
largest-ever mega-analysis of sex differences in variability of brain structure, based
on international data spanning nine decades of life. Subcortical volumes, cortical sur-
face area and cortical thickness were assessed in MRI data of 16,683 healthy individ-
uals 1-90 years old (47% females). We observed significant patterns of greater male
than female between-subject variance for all subcortical volumetric measures, all cor-
tical surface area measures, and 60% of cortical thickness measures. This pattern was
stable across the lifespan for 50% of the subcortical structures, 70% of the regional
area measures, and nearly all regions for thickness. Our findings that these sex differ-
ences are present in childhood implicate early life genetic or gene-environment inter-
action mechanisms. The findings highlight the importance of individual differences
within the sexes, that may underpin sex-specific vulnerability to disorders.
1 | INTRODUCTION
For a diverse set of human traits and behaviors, males are often reported
to show greater variability than females (Hyde 2014). This sex difference
has been noted for aspects of personality (Borkenau, McCrae, and Ter-
racciano 2013), cognitive abilities (Arden and Plomin 2006; Johnson,
Carothers, and Deary 2008; Roalf et al. 2014), and school achievement
(Baye and Monseur 2016). A fundamental question is to what degree
these sex differences are related to genetic mechanisms or social factors,
or their interactions. Lehre et al. (2009) found compelling evidence for
an early genetic or in utero contribution, reporting greater male variabil-
ity in anthropometric traits (e.g. body weight and height, blood parame-
ters) already detectable at birth. Recent studies suggest greater male
variability also in brain structure and its development (Forde et al. 2020;
Ritchie et al. 2018; Wierenga et al. 2018, 2019), but studies with larger
samples that cover both early childhood and old age are critically
needed. Specifically, we do not know when sex differences in variability
in brain structure emerge and whether they change with development
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and throughout life. Yet, data on this could inform us on the origins and
factors that influence this phenomenon. For this reason, we set out to
analyze magnetic resonance imaging (MRI) data from a large sample
of individuals across a very wide age range (n = 16,683, age 1-90) to
robustly characterize sex differences in variability of brain structure
and test how these differences interact with age.
Many prior studies report sex differences in brain structure, but
the specificity, regional pattern and functional relevance of such
effects are not clear (Herting et al. 2018; Koolschijn and Crone 2013;
Marwha, Halari, and Eliot 2017; Ruigrok et al. 2014; Tan et al. 2016).
One reason could be that most studies have examined mean differ-
ences between the sexes, while sex differences in variability remain
understudied (Del Giudice et al. 2016; Joel et al. 2015). As mean and
variance measure two different aspects of the distribution (center and
spread), knowledge on variance effects may provide important insights
into sex differences in the brain. Recent studies observed greater male
variance for subcortical volumes and for cortical surface area to a
larger extent than for cortical thickness (Ritchie et al. 2018; Wierenga
et al. 2018, 2019). However, further studies are needed to explore
regional patterns of variance differences, and, critically, to test how
sex differences in variability in the brain unfold across the lifespan.
An important question pertains to the mechanisms involved in
sex differences in variability. It is hypothesized that the lack of two
parental X-chromosomal copies in human males may directly relate to
greater variability and vulnerability to developmental disorders in
males compared to females (Arnold 2012). All cells in males express
an X-linked variant, while female brain tissues show two variants. In
females, one of the X-chromosomes is randomly silenced, as such
neighboring cells may have different X related genetic expression
(Wu et al. 2014). Consequently, one could expect that in addition to
greater variability across the population, interregional anatomical cor-
relations may be stronger in male relative to female brains. This was
indeed observed for a number of regional brain volumes in children
and adolescents, showing greater within-subject homogeneity across
regions in males than females (Wierenga et al. 2018). These results
remain to be replicated in larger samples as they may provide clues
about mechanisms and risk factors in neurodevelopmental disorders
(e.g. attention-deficit/hyperactivity disorder and autism spectrum dis-
order) that show sex differences in prevalence (Bao and Swaab 2010),
age of onset, heritability rates (Costello et al. 2003), or severity of
symptoms and course (Goldstein, Seidman, and O'brien 2002).
In the present study, we performed mega-analyses on data from
the enhancing neuroimaging genetics through meta-analysis (ENIGMA)
Lifespan working group (Dima et al., 2020; Frangou et al., 2020;
Jahanshad and Thompson 2016). A mega-analysis allows for analyses of
data from multiple sites with a single statistical model that fits all data
and simultaneously accounting for the effect of site. Successfully pooling
lifespan data was recently shown in a study combining 18 datasets to
derive age trends of brain structure (Pomponio et al. 2020). This con-
trasts with meta-analysis where summary statistics are combined and
weighted from data that is analyzed at each site (van Erp et al. 2019).
MRI data from a large sample (n = 16,683) of participants aged 1 to
90 years was included. We investigated subcortical volumes and regional
cortical surface area and thickness. Our first aim was to replicate previ-
ous findings of greater male variability in brain structure in a substantially
larger sample. Based on prior studies (Forde et al. 2020; Ritchie
et al. 2018; Wierenga et al. 2018, 2019) and reports of somewhat
greater genetic effect on surface area than thickness (Eyler et al. 2011;
Kremen et al. 2013), we hypothesized that greater male variance would
be more pronounced for subcortical volumes and cortical surface area
than for cortical thickness, and that greater male variance would be
observed at both upper and lower ends of the distribution. Our second
aim was to test whether observed sex differences in variability of brain
structure are stable across the lifespan from birth until 90 years of age,
or e.g. increase with the accumulation of experiences (Pfefferbaum,
Sullivan, and Carmelli 2004). Third, in line with the single X-chromosome
hypothesis, we aimed to replicate whether males show greater inter-
regional anatomical correlations (i.e. within-subject homogeneity) across
brain regions that show greater male compared to female variance
(Wierenga et al. 2019).
2 | METHODS
2.1 | Participants
The datasets analyzed in the present study were from the Lifespan
working group within the ENIGMA Consortium (Jahanshad and
Thompson 2016). There were 78 independent samples with MRI data,
in total including 16,683 (7,966 males) healthy participants aged
1-90 years from diverse ethnic backgrounds (see detailed descriptions
at the cohort level in Table 1). Samples were drawn from the general
population or were healthy controls in clinical studies. Screening pro-
cedures and the eligibility criteria (e.g. head trauma, neurological his-
tory) may be found in Supplemental Table 1. Participants in each
cohort gave written informed consent at the local sites. Furthermore,
at each site local research ethics committees or Institutional Review
Boards gave approval for the data collection, and all local institutional
review boards permitted the use of extracted measures of the
completely anonymized data that were used in the present study.
2.2 | Imaging data acquisition and processing
For definition of all brain measures, whole-brain T1-weighted anatom-
ical scan were included. Detailed information on scanner model and
image acquisition parameters for each site can be found in Supple-
mental Table 1. T1 weighted scans were processed at the cohort level,
where subcortical segmentation and cortical parcellation were per-
formed by running the T1-weighted images in FreeSurfer using ver-
sions 4.1, 5.1, 5.3 or 6.0 (see Supplemental Table 1 for specifications
per site). This software suite is well validated and widely used, and
documented and freely available online (surfer.nmr.mgh.harvard.edu).
The technical details of the automated reconstruction scheme are
described elsewhere (Dale, Fischl, and Sereno 1999; Fischl et al. 1999,
2002). The outcome variables included volumes of seven subcortical
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TABLE 1 Sex distributions and age of subjects by sample
Sample Total N Sex N
Age
Mean SD Range
EDINBURGH 55 Male 20 23.9 2.5 18.5–28.4
Female 35 23.7 3.1 18.6–30.6
UNIBA 131 Male 67 30.3 10.0 18.0–63.0
Female 64 24.3 6.8 18.0–52.0
Tuebingen 50 Male 22 38.4 11.1 26.0–61.0
Female 28 42.2 12.5 24.0–61.0
GSP 2009 Male 894 27.8 16.8 18.0–90.0
Female 1115 26.7 16.2 18.0–89.0
Melbourne 102 Male 54 19.5 2.9 15.0–25.0
Female 48 19.6 3.1 15.0–26.0
HMS 55 Male 21 41.3 11.2 24.0–59.0
Female 34 38.5 12.8 19.0–64.0
ENIGMA-OCD (1) 66 Male 30 30.6 8.9 19.0–56.0
Female 36 35.1 10.9 18.0–61.0
NUIG 93 Male 54 34.1 11.6 18.0–57.0
Female 39 39.0 11.0 18.0–58.0
NeuroIMAGE 383 Male 177 16.8 3.6 7.7–28.5
Female 206 17.0 3.8 7.8–28.6
CAMH 141 Male 72 43.2 18.9 18.0–86.0
Female 69 44.1 19.8 18.0–82.0
Basel 44 Male 17 25.7 4.5 19.0–35.0
Female 27 25.3 4.2 19.0–39.0
Bordeaux 452 Male 220 26.9 7.8 18.0–57.0
Female 232 26.6 7.7 18.0–56.0
FBIRN 174 Male 124 37.6 11.3 19.0–60.0
Female 50 37.4 11.3 19.0–58.0
KaSP 32 Male 15 27.4 5.5 21.0–43.0
Female 17 27.6 5.9 20.0–37.0
CODE 72 Male 31 43.7 12.4 25.0–64.0
Female 41 36.6 13.4 20.0–63.0
Indiana (1) 49 Male 9 71.9 6.6 63.0–80.0
Female 40 60.4 11.6 37.0–84.0
COMPULS/TS EUROTRAIN 53 Male 36 10.8 1.0 8.7–12.9
Female 17 11.0 1.1 9.2–12.9
FIDMAG 123 Male 54 36.4 8.5 19.0–63.0
Female 69 38.4 11.2 19.0–64.0
NU 79 Male 46 31.6 14.5 14.6–66.3
Female 33 34.4 15.3 14.2–67.9
SHIP-TREND 818 Male 467 50.5 14.4 22.0–81.0
Female 351 49.6 14.0 21.0–81.0
SHIP-2 373 Male 207 55.6 12.8 31.0–84.0
Female 166 54.4 12.0 32.0–88.0
QTIM 340 Male 111 22.5 3.3 16.0–29.3
Female 229 22.7 3.4 16.1–30.0
Betula 287 Male 136 61.6 12.5 25.5–81.3
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TABLE 1 (Continued)
Sample Total N Sex N
Age
Mean SD Range
Female 151 64.1 13.1
TOP 303 Male 159 34.5 8.8 18.3–56.2
Female 144 36.3 10.9 19.3–73.4
HUBIN 102 Male 69 42.1 9.0 19.4–54.9
Female 33 41.7 8.5 19.9–56.2
StrokeMRI 52 Male 19 47.9 20.8 20.0–77.0
Female 33 43.6 23.0 18.0–78.0
AMC 99 Male 65 22.5 3.4 17.0–32.0
Female 34 23.6 3.3 18.0–29.0
NESDA 65 Male 23 40.7 9.7 23.0–56.0
Female 42 40.1 9.9 21.0–54.0
Barcelona (1) 30 Male 14 15.1 1.5 13.0–17.0
Female 16 14.9 2.1 11.0–17.0
Barcelona (2) 44 Male 24 14.4 1.8 11.0–17.0
Female 20 14.8 2.4 11.0–17.0
Stages-Dep 32 Male 9 46.6 8.4 37.0–58.0
Female 23 45.8 8.2 27.0–58.0
IMpACT 144 Male 57 34.2 11.0 19.0–62.0
Female 87 37.2 12.6 19.0–63.0
BIG 1319 Male 657 29.8 15.4 17.0–82.0
Female 662 26.9 12.9 13.0–79.0
IMH Stanford 56 Male 22 36.0 10.5 20.4–60.5
34 Female 34 37.5 10.8 18.9–56.3
MCIC (1) + (2) 93 Male 63 32.8 12.2 18.0–58.0
Female 30 32.5 11.9 19.0–60.0
OLIN 599 Male 237 36.3 13.3 22.0–86.5
Female 362 35.9 12.8 21.0–74.0
Neuroventure 137 Male 62 13.7 0.6 12.4–14.9
Female 75 13.6 0.7 12.3–14.9
CIAM 30 Male 16 27.1 5.9 19.0–40.0
Female 14 26.1 3.8 20.0–33.0
ENIGMA-HIV 31 Male 16 25.6 4.7 19.0–33.0
Female 15 23.9 4.1 20.0–32.0
Meth-CT 62 Female 13 26.1 4.1 19.0–34.0
Males 49 27.0 7.9 18.0–53.0
ENIGMA-OCD 26 Male 10 34.6 13.6 19.0–56.0
Female 16 28.8 7.8 20.0–46.0
Oxford 38 Male 18 16.5 1.6 14.1–18.9
Female 20 15.9 1.1 13.7–17.7
Yale 23 Male 12 14.4 2.4 10.3–17.5
Female 11 14.0 2.0 9.9–16.5
Sao Paulo-1 69 Male 45 27.1 5.6 18.0–42.0
Female 24 27.5 6.4 17.0–43.0
Sao Paulo-3 85 Male 45 28.2 7.3 18.0–43.0
Female 40 32.7 8.8 18.0–50.0
(Continues)
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TABLE 1 (Continued)
Sample Total N Sex N
Age
Mean SD Range
ENIGMA-OCD (2) 49 Male 19 32.1 7.8 24.0–53.0
Female 30 31.3 7.7 21.0–50.0
ENIGMA-OCD (3) 35 Male 16 42.9 12.9 22.5–64.0
Female 19 36.0 8.8 21.5–49.3
ENIGMA-OCD (4) 23 Male 9 13.1 2.9 8.8–15.9
Female 14 13.8 2.4 8.7–16.8
ENIGMA-OCD (5) 33 Male 12 30.7 8.8 21.0–53.0
Female 21 39.2 11.5 24.0–63.0
SYDNEY 157 Male 65 42.0 22.4 12.0–84.0
Female 92 37.1 21.7 13.0–78.0
IMH 79 Male 50 30.7 8.3 23.0–53.9
Female 29 34.2 12.4 20.4–59.0
UPENN 187 Male 86 35.7 12.9 18.0–71.0
Female 101 35.8 14.7 16.0–85.0
ADHD-NF 13 Male 7 13.3 1.2 11.9–14.8
Female 6 13.4 0.8 12.1–14.2
Indiana (2) 66 Male 26 40.2 15.3 19.0–65.0
Female 40 39.4 14.1 20.0–65.0
Sydney MAS 523 Male 236 78.3 4.6 70.3–89.8
Female 287 78.5 4.7 70.5–90.1
OADS (1) 118 Male 39 73.8 5.5 65.0–84.0
Female 79 70.4 5.6 65.0–84.0
Cardiff 318 Male 89 28.1 7.8 19.0–57.0
Female 229 24.2 7.0 18.0–58.0
CEG 32 Male 32 15.6 1.7 13.0–19.0
NYU 51 Male 31 30.2 7.7 18.8–46.0
Female 20 31.4 10.3 19.8–51.9
CLiNG 321 Male 131 25.5 5.4 19.0–58.0
Female 190 24.9 5.1 18.0–57.0
NTR (1) 112 Male 42 28.5 8.0 19.0–56.0
Female 70 37.0 10.5 19.0–57.0
NTR (2) 30 Male 11 28.4 3.6 22.0–33.0
Female 19 28.6 9.8 1.0–42.0
NTR (3) 37 Male 14 15.1 1.5 12.0–17.0
Female 23 14.5 1.4 11.0–18.0
Indiana (2) + (3) 201 Male 97 21.6 14.4 6.0–79.0
Female 104 33.0 22.8 7.0–87.0
BIG 1291 Male 553 25.1 9.3 18.0–71.0
Female 738 23.3 6.9 18.0–66.0
OADS (2) 35 Male 15 70.1 5.7 65.0–81.0
Female 20 67.4 3.8 65.0–78.0
OADS (3) 153 Male 59 70.3 4.2 65.0–81.0
Female 94 69.7 4.6 65.0–81.0
OADS (4) 108 Male 30 69.8 4.5 65.0–85.0
Female 78 70.1 4.9 65.0–89.0
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structures: accumbens, caudate, pallidum, putamen, amygdala, hippo-
campus, and thalamus (Fischl et al. 2002), and cortical surface area
and thickness measures (Dale et al. 1999; Fischl et al. 1999) of
68 regions of the cerebral cortex (Desikan-Killiany atlas) (Desikan
et al. 2006). Quality control was also implemented at the cohort level
following detailed protocols (http://enigma.ini.usc.edu/protocols/
imaging-protocols). The statistical analyses included 13,696 partici-
pants for subcortical volumes, 11,338 for surface area measures, and
12,533 participants for cortical thickness analysis.
2.3 | Statistical analysis
Statistical analyses were performed using R Statistical Software. The
complete scripts are available in the Appendix. In brief, we first adjusted
all brain structure variables for cohort, field strength and FreeSurfer
version effects. As age ranges differed for each cohort this was done in
two steps: initially, a linear model was used to account for cohort effects
and non-linear age effects, using a third-degree polynomial function.
Next, random forest regression modelling (Breiman 2001) was used to
additionally account for field strength and FreeSurfer version. See
Supplemental Figure 1 for adjusted values. This was implemented in the
R package randomForest, which can accommodate models with inter-
actions and non-linear effects.
2.4 | Mean differences
Mean sex differences in brain structure variables were tested using
t-tests (FDR corrected, see (Benjamini and Hochberg 1995)) and
effect sizes were estimated using Cohen's d-value. A negative effect
size indicates that the mean was higher in females, and a positive
effect size indicates it was higher in males. The brain structure vari-
ables were adjusted for age and covariates described above. Graphs
were created with R package ggseg (Mowinckel and Vidal-
Pineiro, 2019).
2.5 | Variance ratio
Variance differences between males and females were examined,
after accounting for age and other covariates as described above.
Fisher's variance ratio (VR) was estimated by dividing variance mea-
sures for males and females. VR was log transformed to account for
VR bias (Katzman and Alliger 1992; Lehre et al. 2009). Letting yi
denote the observed outcome for observation number i and y^i its
predicted outcome, the residuals were then formed:
ri = yi−y^i
The residual variance Varmales and Varfemales were computed sepa-
rately for males and females, and used to form the test statistic
T =Varmales=Varfemales
For each outcome, a permutation test of the hypothesis that the sex
specific standard deviations were equal, was performed. This was done by
random permutation of the sex variable among the residuals. Using β per-
mutations, the p-value for the k-th outcome measure was computed as
pk =
XB
b=1
I Tb > Tð Þ=B
where I(Tb ≥ T) is an indicator function that is 1 when Tb ≥ T, and
0 otherwise. Thus, the p-value is the proportion of permuted test sta-
tistics (Tb) that were greater than the observed value T of the test sta-
tistic above. Here B was set to 10,000. FDR corrected values are
reported as significant.
2.6 | Shift Function
To assess the nature of the variability difference between males and
females, shift functions were estimated for each brain measure that
showed significant variance differences between males and females using
quantile regression forests (Meinshausen 2006; Rousselet, Pernet, and
Wilcox 2017), implemented in the R package quantregForest (see
Wierenga et al. 2018) for a similar approach). First, as described above,
TABLE 1 (Continued)
Sample Total N Sex N
Age
Mean SD Range
MHRC 52 Male 52 22.3 2.9 16.1–27.6
BRAINSCALE 277 Male 146 10.1 1.5 9.0–15.0
Female 131 9.9 1.2 9.0–14.1
Leiden 611 Male 299 16.2 4.7 8.3–28.1
Female 312 16.9 4.9 8.4–28.9
IMAGEN 1964 Male 952 14.5 0.4 13.2–15.7
Female 1012 14.5 0.4 13.3–16.0
ENIGMA-HIV 175 Male 175 38.8 6.5 29.0–50.0
UMCU 172 Male 84 40.2 16.5 18.0–80.0
Female 88 39.2 17.9 18.0–84.0
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brain measures were accounted for site, age, field strength and FreeSurfer
version. Next, quantile distribution functions were estimated for males
and females separately after aligning the distribution means. Let q be a
probability between 0 and 1. The quantile function specifies the values at
which the volume of a brain measure will be at or below any given q. The
quantile function for males is given as Q(qj males) and for females as Q
(qjfemales). The quantile distance function is then defined as:
D qð Þ=Q qjmalesð Þ−Q qjfemalesð Þ
A bootstrap method was used to estimate the standard error of
the quantile difference functions, which was used to form approxi-
mate 95% confidence intervals. If the quantile distance function is a
straight-line parallel to the x axis, this indicates a stable difference
between the sexes across the distribution and thus no detectable dif-
ference in variability. A positive slope indicates greater male variance.
More specifically, this would indicate that the males with the largest
values have relatively larger values than females with the largest
values, and males with the smallest values are relatively smaller values
than the females with the smallest values. A negative slope of the
quantile distance function would indicate larger variability in females
at both ends of the distribution.
2.7 | Variance change with age
To study whether the sex differences in variance are stable across the
age range we used the residuals of the predicted outcome measure
and each individual i:
ri = j yi−y^i j
The absolute value of ri was then used in a regression model. It was
next explored whether there was a significant (FDR corrected) age by
sex interaction effect using a linear model 1 and quadratic model 2:
yi =Agei  sexi + errori model1ð Þ
yi =Age
2
i  sexi + errori model2ð Þ
2.8 | Anatomical correlation analysis
Inter-regional anatomical associations were assessed by defining the
correlation between two brain structures, after accounting for age
and other covariates as described above. Anatomical correlation
matrices were estimated as previously applied in several structural
MRI studies for males and females separately (see e.g. Baaré
et al. 2001; Lerch et al. 2006). Next, the anatomical correlation matrix
for females was subtracted from the anatomical correlation matrix for
males, yielding a difference matrix.
Thus, the Pearson correlation coefficient between any two
regions i and j was assessed for males and females separately. This
produced two group correlation matrices Mij and Fij where i, j, = 1, 2, .
…, N, where N is the number of brain regions.
Sex specific means and standard deviations were removed by per-
forming sex specific standardization. The significance of the differ-
ences between Mij and Fij was assessed by the difference in their
Fisher's z-transformed values, and p-values were computed using per-
mutations. Whether these significantly differed between the sexes
was tested using a Chi-square test.
3 | RESULTS
3.1 | Sex differences in mean and variance
All brain measures were adjusted for cohort, field strength, FreeSurfer
version and (non-linear) age. As a background analysis, we first
assessed whether brain structural measures showed mean differences
between males and females to align our findings to previous reports
(Figure 1, Table 2). All subcortical volumes were significantly larger in
males, with effect sizes (Cohen's d-values) ranging from 0.41 (left
accumbens) to 0.92 (right thalamus), and an average effect size of 0.7.
In follow-up analyses with total brain volume as an additional covari-
ate we found a similar pattern, although effect sizes were smaller
(Supplemental Table S2A). Also for cortical surface area, all regions
showed significantly larger values in males than females, with effect
sizes ranging from 0.42 (left caudal anterior cingulate area) to 0.97
(left superior temporal area), on average 0.71. When total surface area
was included as an additional covariate, a similar pattern was observed,
although effect sizes were smaller (Supplemental Table S2B). Cortical
thickness showed significant mean sex differences in 43 (out of 68)
regions, of which 38 regions showed larger thickness values in
females than males. These were mostly frontal and parietal regions.
The largest effect size, however, was only 0.12 (right caudal anterior
cingulate cortex). When total average cortical thickness was included
as an additional covariate, nine regions showed a male advantage that
was not observed in the raw data analysis, and six of the 38 regions
showing female advantage did not reach significance (Supplemental
Table S2C).
We then tested for sex differences in variance of brain structure,
adjusted for cohort, field strength, FreeSurfer version and (non-linear)
age (Figure 2, Tables 2). All subcortical volumes had significantly
greater variance in males than females. Log transformed variance
ratios ranged from 0.12 (right accumbens) to 0.36 (right pallidum),
indicating greater variance in males than females. Similar results were
also observed when total brain volume was taken into account (Sup-
plemental Table S2A). Cortical surface area also showed significantly
greater variance in males for all regions: variance ratios ranged from
0.13 (left caudal anterior cingulate cortex) to 0.36 (right para-
hippocampal cortex). This pattern was also observed when total sur-
face area was included in the model (Supplemental Table S2B).
Cortical thickness showed significantly greater male variance in
41 out of 68 regions, with the greatest variance ratio being 0.11 (left
precentral cortex). Notably, 37 of these 41 regions did not show
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significantly larger mean thickness values in males. When additionally
accounting for total average thickness, we found greater male vari-
ance in 39 regions and greater females variance in 5 regions. Also
here, significant variance ratios were present in the absence of mean
sex differences (Supplemental Table S2C).
Next, we directly tested whether the regions showing larger vari-
ance effects were also those showing larger mean differences, by cor-
relating the variance ratios with the vector of d-values (Supplemental
Figure 2). There was a significant association for subcortical volumes
(r (12) = 0.7, p-value = .005), but no significant relation for regional
cortical surface area (r (66) = 0.18, p-value = .14), or thickness (r (66) =
-0.21, p-value = .09).
3.2 | Greater variance in males at upper and lower
tails
In order to characterise how the distributions of males and females
differ, quantiles were compared using a shift function (Rousselet
et al. 2017). As in the previous models, brain measures were adjusted
for cohort, field strength, FreeSurfer version and age. In addition, the
distribution means were aligned. Results showed greater male vari-
ance at both upper and lower tails for regions that showed significant
variance differences between males and females. The top three vari-
ance ratio effects for subcortical volume, cortical surface area and cor-
tical thickness are shown in Figure 3.
3.3 | Variance differences between sexes
across age
We next tested whether the sex differences in variance interacted
with age (Figure 4 and supplemental Figure 3). In this set of analyses,
brain measures were adjusted for cohort, field strength, and
FreeSurfer version. For 50% of the subcortical volume measures
there was a significant interaction, specifically for the bilateral thal-
ami, bilateral putamen, bilateral pallidum and the left hippocampus
(Table 3, Figure 5). Cortical surface area showed significant interac-
tion effects in 30% of the cortical regions (Table 3, Figure 5). In both
cases, younger individuals tended to show greater sex differences in
variance than older individuals. For cortical thickness, an interaction
with age was detected only in the left insula (Table 3, Figure 5). This
region showed greater male than female variance in the younger age
group, whereas greater female variance was observed in older
individuals.
Next, these analyses were repeated using a quadratic age model
(Supplemental Tables 3A-C). None of the subcortical or cortical sur-
face area measures showed quadratic age by sex interaction effects in
variance. Cortical thickness showed significant quadratic age by sex
effects in two regions; left superior frontal cortex and right lateral
orbitofrontal cortex.
3.4 | Sex differences in anatomical correlations
Finally, we tested whether females showed greater diversity than
males in anatomical correlations by comparing inter-regional anatomi-
cal associations between males and females. Using permutation test-
ing (B = 10000), the significance of correlation differences between
males and females was assessed.
Of the 91 subcortical-subcortical correlation coefficients, 2%
showed significantly stronger correlations in males, while, unexpect-
edly, 19% showed stronger correlations in females (tested two-sided)
(Figure 6A). A chi-square test of independence showed that this sig-
nificantly differed between males and females, X2 (1, N = 18)
= 10.889, p < .001. For surface area, no significant difference between
males and females were observed: significantly stronger male homo-
geneity was observed in 4% of the 2,278 unique anatomical correla-
tions, and similarly females also showed significantly stronger
correlations in 4% of the anatomical associations (Figure 6B). For
thickness, stronger male than female homogeneity was observed in
21% of the correlations, while stronger female correlations were
observed in <1% of the correlations (Figure 6C). This difference was
significant, X2 (1, N = 484) = 460.300, p < .001.
F IGURE 1 Sex differences in volumetric measures of subcortical volumes (left), cortical surface area (center), and cortical thickness (right).
Shown are effect sizes (Cohen's d-value) of FDR corrected mean sex differences. Greater mean values for males are displayed in blue, greater
mean values for females are displayed in red. Darker colors indicate larger effect sizes
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TABLE 2 Sex differences in mean and variance
(a) Subcortical volume Female (n = 7141) Male (n = 6555)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left thal -328.287 357.024 ** 0.840 0.237 **
Right thal -317.358 345.963 ** 0.918 0.357 **
Left caud -139.573 152.488 ** 0.609 0.150 **
Right caud -147.366 160.706 ** 0.625 0.147 **
Left put -237.405 257.178 ** 0.757 0.197 **
Right put -233.415 252.623 ** 0.786 0.220 **
Left pal -86.166 93.761 ** 0.768 0.317 **
Right pal -74.910 81.507 ** 0.793 0.339 **
Left hippo -137.976 149.409 ** 0.673 0.173 **
Right hippo -134.745 145.724 ** 0.669 0.232 **
Left amyg -73.754 80.305 ** 0.765 0.154 **
Right amyg -80.242 87.372 ** 0.790 0.216 **
Left accumb -22.255 24.369 ** 0.414 0.168 **
Right accumb -22.755 24.685 ** 0.454 0.119 **
(b) Surface area
Female (n = 6243) Male (n = 5092)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left bankssts -45.976 56.715 ** 0.596 0.282 **
Left caudalanteriorcingulate -25.875 31.956 ** 0.420 0.131 **
Left caudalmiddlefrontal -100.326 123.509 ** 0.589 0.163 **
Left cuneus -55.069 67.958 ** 0.605 0.188 **
Left entorhinal -19.379 23.824 ** 0.540 0.310 **
Left fusiform -142.081 174.977 ** 0.794 0.240 **
Left inferiorparietal -203.760 250.694 ** 0.751 0.288 **
Left inferiortemporal -158.709 195.821 ** 0.778 0.193 **
Left isthmuscingulate -54.544 67.228 ** 0.765 0.326 **
Left lateraloccipital -229.910 284.223 ** 0.893 0.240 **
Left lateralorbitofrontal -93.815 115.782 ** 0.771 0.194 **
Left lingual -114.132 141.130 ** 0.630 0.197 **
Left medialorbitofrontal -76.336 94.318 ** 0.741 0.288 **
Left middletemporal -139.909 172.666 ** 0.808 0.227 **
Left parahippocampal -24.273 30.139 ** 0.522 0.330 **
Left paracentral -46.588 57.790 ** 0.578 0.303 **
Left parsopercularis -63.862 78.461 ** 0.536 0.350 **
Left parsorbitalis -27.703 34.060 ** 0.755 0.223 **
Left parstriangularis -55.836 68.926 ** 0.633 0.262 **
Left pericalcarine -48.359 58.895 ** 0.485 0.151 **
Left postcentral -176.934 217.762 ** 0.867 0.286 **
Left posteriorcingulate -50.597 62.161 ** 0.651 0.253 **
Left precentral -207.652 255.826 ** 0.949 0.319 **
Left precuneus -163.276 200.728 ** 0.834 0.266 **
Left rostralanteriorcingulate -40.967 50.637 ** 0.619 0.160 **
Left rostralmiddlefrontal -297.267 365.653 ** 0.934 0.261 **
Left superiorfrontal -330.564 406.757 ** 0.962 0.269 **
Left superiorparietal -202.642 249.403 ** 0.730 0.241 **
Left superiortemporal -177.562 218.916 ** 0.970 0.262 **
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TABLE 2 (Continued)
(b) Surface area
Female (n = 6243) Male (n = 5092)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left supramarginal -205.547 254.230 ** 0.877 0.304 **
Left frontalpole -6.671 8.241 ** 0.439 0.249 **
Left temporalpole -15.185 18.664 ** 0.557 0.224 **
Left transversetemporal -19.898 24.463 ** 0.585 0.239 **
Left insula -84.765 104.782 ** 0.847 0.250 **
Right bankssts -42.654 52.655 ** 0.662 0.261 **
Right caudalanteriorcingulate -31.929 39.489 ** 0.465 0.275 **
Right caudalmiddlefrontal -95.924 117.705 ** 0.563 0.225 **
Right cuneus -61.606 75.541 ** 0.668 0.213 **
Right entorhinal -16.941 20.615 ** 0.467 0.339 **
Right fusiform -155.696 191.647 ** 0.900 0.225 **
Right inferiorparietal -278.411 342.870 ** 0.920 0.325 **
Right inferiortemporal -157.460 193.922 ** 0.827 0.187 **
Right isthmuscingulate -47.046 57.740 ** 0.723 0.314 **
Right lateraloccipital -227.765 282.023 ** 0.876 0.279 **
Right lateralorbitofrontal -99.594 122.823 ** 0.765 0.234 **
Right lingual -110.640 136.478 ** 0.644 0.225 **
Right medialorbitofrontal -70.180 86.695 ** 0.777 0.203 **
Right middletemporal -155.924 192.222 ** 0.857 0.224 **
Right parahippocampal -30.721 37.810 ** 0.708 0.357 **
Right paracentral -57.941 71.375 ** 0.609 0.349 **
Right parsopercularis -53.895 65.892 ** 0.506 0.312 **
Right parsorbitalis -35.086 43.159 ** 0.771 0.197 **
Right parstriangularis -69.557 85.138 ** 0.634 0.252 **
Right pericalcarine -56.327 68.894 ** 0.528 0.145 **
Right postcentral -168.595 208.307 ** 0.851 0.278 **
Right posteriorcingulate -52.836 65.327 ** 0.662 0.237 **
Right precentral -216.995 267.894 ** 0.950 0.341 **
Right precuneus -184.909 228.043 ** 0.878 0.248 **
Right rostralanteriorcingulate -33.179 41.005 ** 0.576 0.221 **
Right rostralmiddlefrontal -294.685 363.055 ** 0.898 0.228 **
Right superiorfrontal -325.198 400.002 ** 0.939 0.258 **
Right superiorparietal -205.624 252.962 ** 0.765 0.216 **
Right superiortemporal -132.506 163.787 ** 0.800 0.243 **
Right supramarginal -168.426 207.920 ** 0.754 0.285 **
Right frontalpole -9.712 11.996 ** 0.481 0.194 **
Right temporalpole -11.097 13.725 ** 0.422 0.228 **
Right transversetemporal -14.315 17.686 ** 0.564 0.194 **
Right insula -95.695 117.482 ** 0.863 0.238 **
(c) Thickness
Female (n = 6620) Male (n = 5913)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left bankssts 0.001 -0.001 n.s. 0.011 0.039 **
Left caudalanteriorcingulate 0.026 -0.028 ** 0.213 -0.042 n.s.
Left caudalmiddlefrontal 0.008 -0.008 ** 0.103 0.061 *
Left cuneus 0.000 0.000 n.s. 0.001 0.050 *
(Continues)
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TABLE 2 (Continued)
(c) Thickness
Female (n = 6620) Male (n = 5913)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Left entorhinal -0.013 0.015 ** 0.084 0.023 n.s.
Left fusiform 0.001 -0.001 n.s. 0.016 0.022 n.s.
Left inferiorparietal 0.009 -0.009 ** 0.128 0.092 **
Left inferiortemporal -0.002 0.003 n.s. 0.027 0.004 n.s.
Left isthmuscingulate 0.009 -0.009 ** 0.088 -0.007 **
Left lateraloccipital 0.005 -0.005 ** 0.074 0.079 **
Left lateralorbitofrontal -0.002 0.003 n.s. 0.036 0.101 **
Left lingual -0.003 0.004 ** 0.058 0.040 n.s.
Left medialorbitofrontal -0.004 0.006 ** 0.058 0.027 n.s.
Left middletemporal -0.003 0.004 n.s. 0.037 0.093 *
Left parahippocampal 0.015 -0.016 ** 0.098 0.016 n.s.
Left paracentral 0.006 -0.005 ** 0.067 0.030 **
Left parsopercularis -0.002 0.003 n.s. 0.027 0.087 **
Left parsorbitalis 0.013 -0.014 ** 0.120 0.071 **
Left parstriangularis 0.004 -0.004 * 0.049 0.084 **
Left pericalcarine 0.000 0.001 n.s. 0.006 0.043 **
Left postcentral 0.008 -0.009 ** 0.133 0.078 **
Left posteriorcingulate 0.004 -0.004 ** 0.052 0.080 **
Left precentral 0.007 -0.007 ** 0.097 0.112 **
Left precuneus 0.000 0.000 n.s. 0.002 0.041 **
Left rostralanteriorcingulate 0.020 -0.021 ** 0.170 -0.046 n.s.
Left rostralmiddlefrontal 0.005 -0.004 ** 0.061 0.112 **
Left superiorfrontal 0.013 -0.014 ** 0.168 0.048 n.s.
Left superiorparietal 0.009 -0.009 ** 0.136 0.098 **
Left superiortemporal -0.001 0.001 n.s. 0.014 0.052 **
Left supramarginal 0.009 -0.009 ** 0.126 0.064 **
Left frontalpole 0.015 -0.016 ** 0.100 0.036 n.s.
Left temporalpole 0.004 -0.004 n.s. 0.023 0.027 n.s.
Left transversetemporal 0.020 -0.021 ** 0.177 0.018 n.s.
Left insula -0.009 0.011 ** 0.121 0.049 n.s.
Right bankssts -0.001 0.002 n.s. 0.016 0.064 **
Right caudalanteriorcingulate 0.027 -0.030 ** 0.242 -0.029 n.s.
Right caudalmiddlefrontal 0.008 -0.009 ** 0.109 0.019 **
Right cuneus 0.003 -0.002 n.s. 0.034 0.027 *
Right entorhinal 0.005 -0.005 n.s. 0.028 0.026 n.s.
Right fusiform 0.001 0.000 n.s. 0.008 0.029 n.s.
Right inferiorparietal 0.008 -0.008 ** 0.110 0.103 **
Right inferiortemporal 0.000 0.001 n.s. 0.003 0.032 n.s.
Right isthmuscingulate 0.010 -0.010 ** 0.099 -0.038 **
Right lateraloccipital 0.004 -0.004 ** 0.057 0.078 **
Right lateralorbitofrontal 0.003 -0.003 n.s. 0.036 0.074 **
Right lingual -0.002 0.003 n.s. 0.036 0.036 n.s.
Right medialorbitofrontal 0.003 -0.003 n.s. 0.033 0.056 n.s.
Right middletemporal -0.003 0.004 * 0.047 0.065 **
Right parahippocampal 0.021 -0.023 ** 0.162 0.028 n.s.
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4 | DISCUSSION
In this study, we analyzed a large lifespan sample of neuroimaging
data from 16,683 participants spanning nine decades of life starting at
birth. Results confirmed the hypothesis of greater male variability in
brain structure (Forde et al. 2020; Ritchie et al. 2018; Wierenga
et al. 2018, 2019). Variance differences were more pronounced for
subcortical volumes and regional cortical surface area than for
regional cortical thickness. We also corroborated prior findings of
greater male brain structural variance at both upper and lower tails of
brain measures (Wierenga et al. 2018). These variance effects seem to
describe a unique aspect of sex differences in the brain that does not
follow the regional pattern of mean sex differences. A novel finding
was that sex differences in variance appear stable across the lifespan
for around 50% of subcortical volumes, 70% of cortical surface area
measures and almost all cortical thickness measures. Unexpectedly,
regions with significant change in variance effects across the age
range showed decreasing variance differences between the sexes
with increasing age. Finally, we observed greater male inter-regional
homogeneity for cortical thickness, but not for surface area or
TABLE 2 (Continued)
(c) Thickness
Female (n = 6620) Male (n = 5913)
Mean difference test
Variance Ratio test
M M p Cohen's d VR p
Right paracentral 0.004 -0.004 ** 0.055 0.065 **
Right parsopercularis 0.000 0.000 n.s. 0.001 0.037 **
Right parsorbitalis 0.018 -0.019 ** 0.164 0.026 n.s.
Right parstriangularis 0.004 -0.004 ** 0.053 0.008 **
Right pericalcarine 0.001 -0.001 n.s. 0.017 0.020 n.s.
Right postcentral 0.009 -0.009 ** 0.135 0.009 **
Right posteriorcingulate 0.007 -0.007 ** 0.082 0.013 **
Right precentral 0.008 -0.009 ** 0.119 0.084 **
Right precuneus -0.001 0.002 n.s. 0.018 0.063 **
Right rostralanteriorcingulate 0.009 -0.010 ** 0.080 0.055 n.s.
Right rostralmiddlefrontal 0.006 -0.006 ** 0.078 0.085 **
Right superiorfrontal 0.013 -0.013 ** 0.165 0.065 *
Right superiorparietal 0.008 -0.009 ** 0.132 0.065 **
Right superiortemporal -0.003 0.004 * 0.042 0.073 **
Right supramarginal 0.006 -0.007 ** 0.086 0.096 **
Right frontalpole 0.021 -0.022 ** 0.140 0.012 n.s.
Right temporalpole -0.006 0.007 * 0.038 0.023 n.s.
Right transversetemporal 0.011 -0.031 ** 0.095 0.101 *
Right insula -0.008 0.010 ** 0.107 0.092 **
* p < 0.05, ** p < 0.01, both after FDR correction.
F IGURE 2 Sex differences in variance ratio for subcortical volumes (Left), cortical surface area (center), and cortical thickness (right). Shown
are log transformed variance ratios, where significant larger variance ratio for males than females is displayed in blue ranging from 0 to 1. Darker
colors indicate a larger variance ratio
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subcortical volumes, partly replicating prior results of greater within-
subject homogeneity in the male brain (Wierenga et al. 2018). Unex-
pectedly, subcortical regions showed stronger interregional correla-
tion in females than in males.
Greater male variance was most pronounced in brain regions
involved in planning, regulation and inhibition of motor movements (pal-
lidum, right inferior parietal cortex and paracentral region), episodic
memory (hippocampus), and multimodal sensory integration (thalamus)
(Aron, Robbins, and Poldrack 2004; Burgess, Maguire, and O'Keefe
2002; Grillner et al. 2005). In addition, the early presence of sex differ-
ences in brain structural variability may be indicative of genetic effects,
in line with findings in a pediatric sample (Wierenga et al. 2018). We also
observed that sex differences in structural variation are either stable or
may reduce in old age. Longitudinal designs are, however, needed to
address the mechanisms underlying this observation.
The expression of greater male variability in both upper and lower
tails of the distribution may be related to architectural and geometric
constraints that are critical for a delicate balance for effective local-
global communication. For example, neurons only partly regulate their
size, and the number of neural connections does not vary strongly
with neocortical size across species (Stevens 1989). Although axon
size and myelin can compensate firing rates in larger brains by speed-
ing up conduction time, there is a limited energy budget to optimize
both volume and conduction time (Buzsáki, Logothetis, and
Singer 2013). As such, extreme brain structure (in both directions)
may come at a cost. This is in line with recent findings that show that
F IGURE 3 Jittered marginal distribution scatterplots are displayed together with their shift function for the top three variance ratio effects of
subcortical volumes (top), cortical surface area (middle) and cortical thickness (right). The central, darkest line on each distribution is the median,
note that main sex effects are removed. The other lines mark the deciles of each distribution. The shift values are included, which refer to the
number of units that the male (upper) distribution would have to be shifted to match the female (lower) distribution. Confidence intervals are
included for each of these shift values
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extreme neural activity patterns may induce suboptimal expressions
of mental states (Northoff and Tumati 2019). Interestingly, it has been
found that individuals with autism spectrum disorder show atypical
patterns of brain structure and development in both the upper and
lower range (Zabihi et al. 2019), suggesting a possible link between
greater male variability and vulnerability for developmental disorders
(see also Alnæs et al. 2019)). Together with our findings, this opens up
new approaches to understanding sex biased developmental disor-
ders, beyond group-level mean differences.
Although most results showed stable sex differences with
increasing age, half of the subcortical regions and a quarter of the cor-
tical surface area measures showed decreasing sex differences in vari-
ance. What stands out is that in all these regions, sex differences in
variance were largest in young compared to older age. This is indica-
tive of early mechanisms being involved. Furthermore, for subcortical
regions, the patterns showed larger volumetric increases in females
then in males. For surface area, interaction effects showed mostly sta-
ble variance across age in females, but decreases in variability in
males. The observation that there were no significant quadratic inter-
actions makes it unlikely that pubertal hormones may affect greater
male variance. Yet, the decrease in male variance in older age, may be
indicative of environmental effects later in life. Alternative explanation
may be the larger number of clinical or even death rates in males that
may lead to some sex difference in survival (Chen et al. 2008; Ryan
et al. 1997).
Factors underlying or influencing sex differences in the brain may
include sex chromosomes, sex steroids (both perinatal or pubertal),
and the neural embedding of social influences during the life span
(Dawson, Ashman, and Carver 2000). Although we could not directly
test these mechanisms, our findings of greater male variance, that are
mostly stable across age, together with the greater male inter-regional
homogeneity for cortical thickness are most in line with the single X-
chromosome expression in males compared to the mosaic pattern of
X-inactivation in females (Arnold 2012). Whereas female brain tissue
shows two variants of X-linked genes, males only show one. This
mechanism may lead to increased male vulnerability, as is also seen
for a number of rare X-linked genetic mutations (Chen et al. 2008;
Craig, Haworth, and Plomin 2009; Johnson, Carothers, and
Deary 2009; Reinhold and Engqvist 2013; Ryan et al. 1997). None of
the other sex effects mentioned above predict these specific inter and
intra-individual sex differences in brain patterns. Future studies are,
however, needed to directly test these different mechanisms. Further-
more, the observation that greater male homogeneity was only
observed in cortical thickness, but not cortical surface area or subcor-
tical volumes, may speculatively indicate that X-chromosome related
genetic mechanisms may have the largest effect on cortical thickness
measures.
This paper has several strengths including its sample size, the age
range spanning nine decades, the inclusion of different structural mea-
sures (subcortical volumes and cortical surface area and thickness)
and the investigation of variance effects. These points are important,
as most observed mean sex differences in the brain are modest in size
(Joel and Fausto-Sterling 2016). We were able to analyze data from a
far larger sample than those included in recent meta-analyses of mean
sex differences (Marwha et al. 2017; Ruigrok et al. 2014; Tan
et al. 2016), and a very wide age range covering childhood, adoles-
cence, adulthood and senescence. The results of this study may have
important implications for studies on mean sex differences in brain
structure, as analyses in such studies typically assume that group vari-
ances are equal, which the present study shows might not be tenable.
This can be particularly problematic for studies with small sample sizes
(Rousselet et al. 2017).
The current study has some limitations. First, the multi-site sam-
ple was heterogeneous and specific samples were recruited in differ-
ent ways, not always representative of the entire population.
Furthermore, although structural measures may be quite stable across
different scanners, the large number of sites may increase the vari-
ance in observed MRI measures, but this would be unlikely to be sys-
tematically biased with respect to age or sex. In addition, variance
effects may change in non-linear ways across the age-range. This may
F IGURE 4 Regions where sex differences in variability of brain structure interacted with age displayed for subcortical volumes (left), cortical
surface area (center), and cortical thickness (right)
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TABLE 3 Variance differences between sexes across age
(a) Subcortical Intercept SE p Age SE p Sex SE P Sex by age SE p
Left thal 587.987 6.178 ** 9398.523 652.185 ** 60.310 9.199 ** -3107.885 979.201 **
Right thal 515.416 5.524 ** 6424.232 583.119 ** 82.380 8.225 ** -3102.267 875.503 **
Left caud 361.790 3.729 ** 879.545 393.693 * 28.152 5.553 ** 270.769 591.096 n.s.
Right caud 371.773 3.785 ** 1290.352 399.567 ** 31.395 5.636 ** -561.719 599.915 n.s.
Left put 495.399 5.150 ** 4435.730 543.701 ** 54.586 7.669 ** -2966.533 816.321 **
Right put 460.842 4.887 ** 5622.177 515.939 ** 51.687 7.277 ** -3853.454 774.638 **
Left pal 165.039 1.816 ** 837.030 191.768 ** 26.852 2.705 ** -784.363 287.923 *
Right pal 140.799 1.598 ** 910.463 168.695 ** 26.247 2.379 ** -850.994 253.281 **
Left hippo 309.722 3.308 ** 2755.892 349.231 ** 31.626 4.926 ** -1375.500 524.341 *
Right hippo 305.607 3.264 ** 2615.969 344.571 ** 35.732 4.860 ** -890.970 517.345 n.s.
Left amyg 148.932 1.598 ** 1378.267 168.734 ** 13.800 2.380 ** -233.236 253.340 n.s.
Right amyg 154.218 1.645 ** 1621.298 173.675 ** 16.477 2.450 ** -540.141 260.758 n.s.
Left accumb 82.473 0.875 ** 442.922 92.410 ** 7.382 1.303 ** -136.472 138.746 n.s.
Right accumb 78.541 0.823 ** 539.975 86.850 ** 7.412 1.225 ** -106.522 130.398 n.s.
Surface area Intercept SE p Age SE p Sex SE p Sex by age SE p
Left bankssts 127.133 1.376 ** -437.616 142.554 ** 16.563 2.056 ** -574.105 219.785 *
Left caudalanteriorcingulate 104.209 1.113 ** -302.669 115.254 ** 4.299 1.663 ** -277.614 177.695 n.s.
Left caudalmiddlefrontal 293.750 2.943 ** -1359.284 304.791 ** 21.272 4.397 ** -660.300 469.918 n.s.
Left cuneus 154.129 1.607 ** -360.698 166.430 * 13.158 2.401 ** -330.457 256.596 n.s.
Left entorhinal 57.126 0.651 ** -458.398 67.397 ** 9.241 0.972 ** 1.893 103.911 n.s.
Left fusiform 305.090 3.105 ** 250.591 321.575 n.s. 35.738 4.639 ** -2446.584 495.794 **
Left inferiorparietal 454.916 4.708 ** -614.521 487.682 n.s. 63.459 7.035 ** -2243.805 751.894 *
Left inferiortemporal 352.394 3.540 ** -353.703 366.628 n.s. 31.482 5.289 ** -1652.239 565.256 *
Left isthmuscingulate 116.771 1.249 ** -32.188 129.411 n.s. 19.544 1.867 ** -204.545 199.522 n.s.
Left lateraloccipital 438.089 4.474 ** -1416.631 463.377 ** 50.571 6.685 ** -813.654 714.421 n.s.
Left lateralorbitofrontal 208.173 2.120 ** 204.108 219.597 n.s. 20.633 3.168 ** -1428.745 338.567 **
Left lingual 310.573 3.141 ** -234.334 325.364 n.s. 29.898 4.694 ** -1268.288 501.636 *
Left medialorbitofrontal 172.506 1.795 ** 3.188 185.938 n.s. 23.450 2.682 ** -213.946 286.673 n.s.
Left middletemporal 296.794 2.997 ** -421.492 310.480 n.s. 31.627 4.479 ** -1014.822 478.689 n.s.
Left parahippocampal 72.669 0.887 ** -211.577 91.839 * 10.825 1.325 ** -241.097 141.595 n.s.
Left paracentral 133.446 1.419 ** -195.857 147.019 n.s. 19.139 2.121 ** -171.708 226.670 n.s.
Left parsopercularis 193.582 2.113 ** -540.023 218.880 * 31.583 3.158 ** -459.911 337.462 n.s.
Left parsorbitalis 61.886 0.643 ** -172.940 66.566 ** 7.120 0.960 ** -131.612 102.629 n.s.
Left parstriangularis 148.566 1.524 ** -644.966 157.820 ** 19.173 2.277 ** -546.829 243.322 n.s.
Left pericalcarine 171.607 1.690 ** -245.127 175.004 n.s. 13.803 2.525 ** -283.583 269.815 n.s.
Left postcentral 340.927 3.572 ** -1033.492 370.007 ** 46.097 5.338 ** -1240.366 570.466 n.s.
Left posteriorcingulate 130.459 1.363 ** -176.189 141.217 n.s. 13.905 2.037 ** -400.954 217.724 n.s.
Left precentral 360.893 3.926 ** -1088.967 406.693 ** 47.580 5.867 ** -876.707 627.028 n.s.
Left precuneus 329.439 3.386 ** -444.670 350.720 n.s. 44.718 5.060 ** -1691.713 540.730 *
Left rostralanteriorcingulate 113.700 1.156 ** -6.807 119.754 n.s. 7.691 1.728 ** -80.447 184.632 n.s.
Left rostralmiddlefrontal 541.319 5.553 ** -1574.677 575.208 ** 63.888 8.298 ** -2391.074 886.838 *
Left superiorfrontal 577.465 6.015 ** -1306.494 623.063 * 75.007 8.988 ** -2320.740 960.620 n.s.
Left superiorparietal 471.735 4.793 ** -1198.240 496.487 * 57.076 7.162 ** -2051.708 765.468 *
Left superiortemporal 308.552 3.215 ** -864.236 333.037 ** 40.486 4.804 ** -1222.034 513.467 n.s.
Left supramarginal 392.296 4.082 ** -1937.799 422.787 ** 58.041 6.099 ** -775.470 651.841 n.s.
Left frontalpole 25.431 0.265 ** -114.432 27.425 ** 3.212 0.396 ** -7.992 42.283 n.s.
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TABLE 3 (Continued)
Surface area Intercept SE p Age SE p Sex SE p Sex by age SE p
Left temporalpole 45.410 0.478 ** -173.235 49.555 ** 5.115 0.715 ** -59.323 76.403 n.s.
Left transversetemporal 56.992 0.594 ** -201.824 61.535 ** 6.690 0.888 ** -81.655 94.872 n.s.
Left insula 164.339 1.842 ** -460.767 190.830 * 17.215 2.753 ** 6.824 294.215 n.s.
Right bankssts 107.290 1.139 ** -392.600 117.986 ** 13.575 1.702 ** -493.453 181.908 *
Right caudalanteriorcingulate 114.549 1.199 ** -266.524 124.192 * 14.948 1.792 ** -8.218 191.475 n.s.
Right caudalmiddlefrontal 288.671 2.929 ** -1415.348 303.395 ** 30.576 4.377 ** -360.883 467.765 n.s.
Right cuneus 152.647 1.656 ** -146.322 171.565 n.s. 16.151 2.475 ** -436.462 264.513 n.s.
Right entorhinal 57.865 0.641 ** -455.979 66.351 ** 10.302 0.957 ** -50.231 102.298 n.s.
Right fusiform 295.259 3.000 ** 43.695 310.723 n.s. 32.408 4.483 ** -1812.528 479.064 **
Right inferiorparietal 504.767 5.239 ** -577.142 542.646 n.s. 82.015 7.828 ** -2767.949 836.635 **
Right inferiortemporal 327.236 3.331 ** -482.481 345.043 n.s. 28.512 4.978 ** -1116.568 531.977 n.s.
Right isthmuscingulate 105.700 1.157 ** -228.263 119.818 n.s. 16.311 1.729 ** -192.830 184.732 n.s.
Right lateraloccipital 436.925 4.537 ** -1283.916 469.975 ** 58.726 6.780 ** -1927.057 724.593 *
Right lateralorbitofrontal 220.527 2.284 ** 236.472 236.616 n.s. 24.442 3.413 ** -1470.759 364.808 **
Right lingual 289.568 3.001 ** -299.806 310.855 n.s. 34.596 4.484 ** -1128.138 479.266 n.s.
Right medialorbitofrontal 154.743 1.568 ** 74.312 162.424 n.s. 15.452 2.343 ** -964.430 250.420 **
Right middletemporal 309.733 3.171 ** -517.078 328.408 n.s. 34.194 4.738 ** -1188.068 506.329 n.s.
Right parahippocampal 70.171 0.781 ** -155.100 80.940 n.s. 11.822 1.168 ** -420.498 124.790 **
Right paracentral 156.024 1.669 ** -273.907 172.868 n.s. 25.570 2.494 ** -271.297 266.523 n.s.
Right parsopercularis 174.570 1.866 ** -1036.595 193.296 ** 25.454 2.789 ** -231.029 298.018 n.s.
Right parsorbitalis 77.607 0.794 ** -103.424 82.287 n.s. 7.160 1.187 ** -311.879 126.867 *
Right parstriangularis 184.989 1.887 ** -925.697 195.494 ** 21.344 2.820 ** -662.628 301.407 n.s.
Right pericalcarine 184.490 1.818 ** -314.748 188.350 n.s. 13.276 2.717 ** -264.356 290.392 n.s.
Right postcentral 330.886 3.494 ** -1175.639 361.875 ** 44.061 5.220 ** -907.204 557.928 n.s.
Right posteriorcingulate 133.953 1.413 ** 42.583 146.371 n.s. 14.739 2.112 ** -695.150 225.670 *
Right precentral 374.619 4.131 ** -1039.063 427.849 * 53.576 6.172 ** -579.997 659.645 n.s.
Right precuneus 355.783 3.685 ** -894.373 381.705 * 42.292 5.507 ** -1788.652 588.501 *
Right rostralanteriorcingulate 97.009 1.005 ** 198.486 104.078 n.s. 10.668 1.501 ** -140.756 160.464 n.s.
Right rostralmiddlefrontal 560.924 5.691 ** -2015.333 589.514 ** 60.682 8.504 ** -1467.830 908.895 n.s.
Right superiorfrontal 586.059 6.054 ** -748.583 627.121 n.s. 72.274 9.047 ** -3613.685 966.876 **
Right superiorparietal 453.081 4.716 ** -1983.725 488.528 ** 49.530 7.048 ** 42.170 753.197 n.s.
Right superiortemporal 281.023 2.898 ** -481.481 300.133 n.s. 31.844 4.330 ** -1005.995 462.736 n.s.
Right supramarginal 376.538 3.839 ** -1315.029 397.627 ** 51.001 5.736 ** -1362.209 613.049 n.s.
Right frontalpole 34.322 0.352 ** -93.541 36.451 * 2.974 0.526 ** -112.046 56.199 n.s.
Right temporalpole 44.173 0.457 ** -144.791 47.330 ** 5.067 0.683 ** -32.370 72.972 n.s.
Right transversetemporal 43.342 0.436 ** -122.601 45.112 ** 4.348 0.651 ** -76.872 69.553 n.s.
Right insula 185.386 1.947 ** 167.564 201.684 n.s. 22.970 2.910 ** -270.419 310.950 n.s.
Thickness Intercept SE p Age SE p Sex SE p Sex by age SE p
Left bankssts 0.138 0.001 ** 0.012 0.150 n.s. 0.002 0.002 n.s. 0.345 0.217 n.s.
Left caudalanteriorcingulate 0.204 0.002 ** 1.405 0.217 ** -0.005 0.003 n.s. 0.207 0.314 n.s.
Left caudalmiddlefrontal 0.119 0.001 ** 0.375 0.131 ** 0.002 0.002 n.s. -0.108 0.190 n.s.
Left cuneus 0.108 0.001 ** -0.194 0.118 n.s. 0.003 0.002 n.s. -0.386 0.171 n.s.
Left entorhinal 0.263 0.003 ** 0.348 0.288 n.s. 0.001 0.004 n.s. -0.414 0.417 n.s.
Left fusiform 0.114 0.001 ** 0.484 0.125 ** 0.000 0.002 n.s. -0.340 0.181 n.s.
Left inferiorparietal 0.109 0.001 ** 0.329 0.122 ** 0.005 0.002 ** 0.023 0.176 n.s.
Left inferiortemporal 0.128 0.001 ** 0.515 0.138 ** 0.000 0.002 n.s. -0.327 0.199 n.s.
(Continues)
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TABLE 3 (Continued)
Thickness Intercept SE p Age SE p Sex SE p Sex by age SE p
Left isthmuscingulate 0.165 0.002 ** 0.491 0.175 ** -0.003 0.002 n.s. -0.076 0.254 n.s.
Left lateraloccipital 0.096 0.001 ** 0.132 0.106 n.s. 0.004 0.001 ** 0.057 0.154 n.s.
Left lateralorbitofrontal 0.124 0.001 ** 0.212 0.138 n.s. 0.006 0.002 ** -0.438 0.201 n.s.
Left lingual 0.099 0.001 ** 0.343 0.109 ** 0.001 0.001 n.s. -0.308 0.157 n.s.
Left medialorbitofrontal 0.135 0.001 ** 0.067 0.150 n.s. 0.004 0.002 n.s. -0.425 0.217 n.s.
Left middletemporal 0.129 0.001 ** 0.493 0.140 ** 0.004 0.002 * -0.012 0.203 n.s.
Left parahippocampal 0.248 0.002 ** 0.441 0.254 n.s. 0.002 0.003 n.s. -0.372 0.368 n.s.
Left paracentral 0.126 0.001 ** 0.321 0.138 * 0.003 0.002 n.s. -0.017 0.199 n.s.
Left parsopercularis 0.123 0.001 ** 0.497 0.134 ** 0.005 0.002 ** -0.358 0.194 n.s.
Left parsorbitalis 0.178 0.002 ** -0.413 0.192 * 0.004 0.003 n.s. 0.266 0.278 n.s.
Left parstriangularis 0.134 0.001 ** 0.145 0.144 n.s. 0.004 0.002 * -0.073 0.209 n.s.
Left pericalcarine 0.101 0.001 ** 0.202 0.114 n.s. 0.001 0.002 n.s. -0.325 0.165 n.s.
Left postcentral 0.097 0.001 ** 0.340 0.106 ** 0.004 0.001 ** 0.222 0.154 n.s.
Left posteriorcingulate 0.131 0.001 ** 0.308 0.142 * 0.005 0.002 ** -0.236 0.205 n.s.
Left precentral 0.110 0.001 ** 1.223 0.122 ** 0.004 0.002 * 0.181 0.177 n.s.
Left precuneus 0.111 0.001 ** 0.521 0.121 ** 0.003 0.002 n.s. -0.056 0.176 n.s.
Left rostralanteriorcingulate 0.193 0.002 ** 0.470 0.205 * -0.005 0.003 n.s. -0.378 0.298 n.s.
Left rostralmiddlefrontal 0.109 0.001 ** 0.153 0.122 n.s. 0.005 0.002 ** 0.039 0.177 n.s.
Left superiorfrontal 0.124 0.001 ** 0.505 0.137 ** 0.002 0.002 n.s. 0.083 0.198 n.s.
Left superiorparietal 0.099 0.001 ** 0.158 0.109 n.s. 0.004 0.001 ** 0.224 0.158 n.s.
Left superiortemporal 0.129 0.001 ** 0.832 0.139 ** 0.004 0.002 * -0.123 0.201 n.s.
Left supramarginal 0.114 0.001 ** 0.396 0.122 ** 0.005 0.002 ** 0.063 0.177 n.s.
Left frontalpole 0.241 0.002 ** -1.236 0.266 ** 0.004 0.004 n.s. 0.112 0.386 n.s.
Left temporalpole 0.268 0.003 ** -2.010 0.301 ** 0.006 0.004 n.s. -0.518 0.436 n.s.
Left transversetemporal 0.182 0.002 ** 0.027 0.194 n.s. -0.001 0.003 n.s. -0.168 0.281 n.s.
Left insula 0.125 0.001 ** 1.184 0.135 ** 0.002 0.002 n.s. -0.700 0.195 *
Right bankssts 0.146 0.001 ** -0.094 0.157 n.s. 0.003 0.002 n.s. 0.217 0.228 n.s.
Right caudalanteriorcingulate 0.186 0.002 ** 0.936 0.198 ** -0.008 0.003 ** -0.105 0.288 n.s.
Right caudalmiddlefrontal 0.120 0.001 ** 0.226 0.130 n.s. 0.002 0.002 n.s. 0.179 0.189 n.s.
Right cuneus 0.110 0.001 ** 0.037 0.118 n.s. 0.001 0.002 n.s. -0.334 0.170 n.s.
Right entorhinal 0.288 0.003 ** 0.122 0.310 n.s. 0.004 0.004 n.s. -0.746 0.449 n.s.
Right fusiform 0.114 0.001 ** 0.657 0.125 ** 0.001 0.002 n.s. -0.171 0.181 n.s.
Right inferiorparietal 0.109 0.001 ** 0.390 0.120 ** 0.005 0.002 ** 0.233 0.174 n.s.
Right inferiortemporal 0.124 0.001 ** 0.539 0.135 ** 0.003 0.002 n.s. -0.132 0.196 n.s.
Right isthmuscingulate 0.162 0.002 ** 0.401 0.172 * -0.002 0.002 n.s. 0.223 0.249 n.s.
Right lateraloccipital 0.101 0.001 ** 0.280 0.110 * 0.005 0.001 ** 0.023 0.159 n.s.
Right lateralorbitofrontal 0.129 0.001 ** -0.174 0.144 n.s. 0.004 0.002 * -0.110 0.208 n.s.
Right lingual 0.102 0.001 ** 0.172 0.111 n.s. 0.000 0.002 n.s. -0.201 0.161 n.s.
Right medialorbitofrontal 0.142 0.001 ** -0.424 0.156 ** 0.003 0.002 n.s. -0.201 0.227 n.s.
Right middletemporal 0.123 0.001 ** 0.067 0.137 n.s. 0.006 0.002 ** 0.400 0.198 n.s.
Right parahippocampal 0.207 0.002 ** 0.554 0.224 * 0.005 0.003 n.s. -0.115 0.325 n.s.
Right paracentral 0.124 0.001 ** 0.492 0.134 ** 0.002 0.002 n.s. -0.050 0.194 n.s.
Right parsopercularis 0.131 0.001 ** 0.330 0.139 * 0.001 0.002 n.s. -0.056 0.201 n.s.
Right parsorbitalis 0.175 0.002 ** -0.470 0.188 * 0.002 0.003 n.s. 0.159 0.273 n.s.
Right parstriangularis 0.131 0.001 ** -0.016 0.141 n.s. 0.002 0.002 n.s. 0.052 0.204 n.s.
Right pericalcarine 0.102 0.001 ** 0.199 0.112 n.s. 0.002 0.002 n.s. -0.336 0.163 n.s.
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be particularly apparent for surface area and subcortical volume mea-
sures, as these showed pronounced non-linear developmental pat-
terns through childhood and adolescence (Tamnes et al. 2017;
Wierenga et al. 2018). Also, the imbalanced number of subjects across
the age range may have diminished variability effects in the older part
of the age range. The present study has a cross-sectional design.
Future studies including longitudinal data are warranted to further
explore the lifespan dynamics of sex differences in variability in the
brain. Last, one caveat may be the effect of movement on data quality
and morphometric measures. As males have been shown to move
more than females in the scanner (Pardoe, Kucharsky Hiess, and
Kuzniecky 2016), this may have resulted in slight under estimations of
brain volume and thickness measures for males (Reuter et al. 2015).
Although quality control was conducted at each site using the stan-
dardized ENIGMA cortical and subcortical quality control protocols
(http://enigma.ini.usc.edu/protocols/imaging-protocols/), which
involve a combination of statistical outlier detection and visual quality
checks and a similar number of males and females had partially miss-
ing data (52.4% males), we cannot exclude the possibility that in-
scanner subject movement may have affected the results. Neverthe-
less, we do not think this can explain our finding of greater male vari-
ance in brain morphometry measures, as this was seen at both the
upper and lower ends of the distributions.
5 | CONCLUSIONS
The present study included a large lifespan sample and robustly con-
firmed previous findings of greater male variance in brain structure in
humans. We found greater male variance in all brain measures, includ-
ing subcortical volumes and regional cortical surface area and thick-
ness, at both the upper and the lower end of the distributions. The
results have important implications for the interpretation of studies
on (mean) sex differences in brain structure. Furthermore, the results
of decreasing sex differences in variance across age opens a new
direction for research focusing on lifespan changes in variability within
sexes. Our findings of sex differences in regional brain structure being
present already in childhood may suggest early genetic or gene-
environment interaction mechanisms. Further insights into the ontog-
eny and causes of variability differences in the brain may provide
clues for understanding male biased neurodevelopmental disorders.
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F IGURE 6 (a–c) Stronger anatomical correlations for males than females are indicated in blue (larger homogeneity in males than females),
while stronger correlations for females are displayed in red (larger homogeneity in females than males). The bottom left half shows the significant
variance ratio's only, using two sided permutation testing. Results are displayed for subcortical volumes (a), surface area (b), and cortical thickness
(c). Cortical regions are ordered by lobe and hemisphere (left frontal, left occipital, left parietal, left temporal, right frontal, right occipital, right
parietal, right temporal)
WIERENGA ET AL. 25
(CUBRIC) and the National Centre for Mental Health (NCMH) for their
support. CEG (London): UK Medical Research Council Grant G03001896
to J Kuntsi; NIHR Biomedical Research Centre for Mental Health, NIHR/
MRC (14/23/17); NIHR senior investigator award (NF-SI-0616-10040).
CIAM: University Research Committee, University of Cape Town; National
Research Foundation; South African Medical Research Council. CODE –
Berlin: Lundbeck; the German Research Foundation (WA 1539/4-1,
SCHN 1205/3-1). Conzelmann Study: Deutsche Forschungsgemeinschaft
(KFO 125, TRR 58/A1 and A5, SFB-TRR 58/B01, B06 and Z02,
RE1632/5-1); EU H2020 (#667302); German Research Foundation (KFO
125). ENIGMA Core: NIA T32AG058507; NIH/NIMH 5T32MH073526;
NIH grant U54EB020403 from the Big Data to Knowledge (BD2K)
Program; Core funding NIH Big Data to Knowledge (BD2K) program
under consortium grant U54 EB020403; ENIGMA World Aging Center
(R56 AG058854; PI PMT); ENIGMA Sex Differences Initiative (R01
MH116147; PI PMT); ENIGMA Suicidal Thoughts and Behavior Working
Group (R01 MH117601; PI NJ). ENIGMA Lifespan: National Institute of
Mental Health (R01MH113619, R01MH116147, R01 MH104284);
National Institute for Health Research (NIHR) Biomedical Research Centre
at South London and Maudsley NHS Foundation Trust and King's College
London; Psychiatry Research Trust; 2014 NARSAD Young Investigator
Award; National Institute of Aging (R03AG064001); National Institute of
General Medical Sciences (P20GM130447); ENIGMA-HIV (NHIV; HIV-
R01): NIH grant MH085604. ENIGMA-OCD (IDIBELL): FI17/00294
(Carlos III Health Institute). PI16/00889; CPII16/00048 (Carlos III Health
Institute). ENIGMA-OCD (London Cohort/Mataix-Cols): Wellcome Trust
and a pump priming grant from the South London and Maudsley Trust,
London, UK (Project grant no. 064846). ENIGMA-OCD (van den Heuvel
1.5T; van den Heuvel 3T): The Dutch Organization for Scientific Research
(NWO-ZonMw) VENI grant 916.86.036; NARSAD Young Investigators
Award; Netherlands Brain Foundation grant 2010(1)-50. ENIGMA-OCD-
3T-CONTROLS: South African Medical Research Council (SA MRC);
South African National Research Foundation (NRF). FIDMAG: Generalitat
de Catalunya (2017SGR01271); several grants funded by Instituto de
Salud Carlos III co-funded by the European Regional Development Fun-
d/European Social Fund “Investing in your future”: Miguel Servet Research
Contract (CPII16/00018 to EP-C, CPII19/00009 to JR) and Research
Projects (PI18/00810 to EP-C, PI18/00877 to RS, and PI19/00394 to JR);
AGAUR; CIBERSAM. GSP: R01MH120080, K01MH099232,
R00MH101367, R01MH119243; R01MH101486; K24 MH094614. We
thank Randy Buckner for access to this dataset. Homburg Multidiagnosis
Study (HMS) - Gottingen, CLING: CLING/HMS: The CliNG study sample
was partially supported by the Deutsche Forschungsgemeinschaft (DFG)
via the Clinical Research Group 241 “Genotype-phenotype relationships
and neurobiology of the longitudinal course of psychosis,” TP2
(PI Gruber; http://www.kfo241.de; grant number GR 1950/5-1); data
storage service SDS@hd supported by the Ministry of Science, Research
and the Arts Baden-Württemberg (MWK) and the German Research
Foundation (DFG) through grant INST 35/1314-1 FUGG and INST
35/1503-1 FUGG. HUBIN: Swedish Research Council (2003-5485,
F IGURE 6 (Continued)
26 WIERENGA ET AL.
2006-2992, 2006-986, 2008-2167, K2012-61X-15078-09-3,
521-2011-4622, 521-2014-3487, 2017-00949); regional agreement
on medical training and clinical research between Stockholm County
Council and the Karolinska Institutet; Knut and Alice Wallenberg
Foundation; HUBIN project. IDIBELL: Carlos III Health Institute
(PI13/01958, PI16/00889, CPII16/00048); FEDER funds/European
Regional Development Fund (ERDF) - a way to build Europe-; the
Department of Health of the Generalitat de Catalunya (PERIS
SLT006/17/249); AGAUR (2017 SGR 1262). IMpACT-NL: The Neth-
erlands Organization for Scientific Research (NWO), i.e. the Veni Inno-
vation Program (grant 016-196-115 to MH) and the Vici Innovation
Program (grant 016–130-669 to BF); U54 EB020403 to the ENIGMA
Consortium from the BD2K Initiative, a cross-NIH partnership, and by
the European College of Neuropsychopharmacology (ECNP) Network
“ADHD Across the Lifespan”; The Dutch National Science Agenda
NeurolabNL project (grant 400-17-602). Indiana 1.5T; Indiana 3T:
NIH grants P30 AG010133, R01 AG019771 and R01 CA129769; Sie-
mens Medical Solutions; the members of the Partnership for Pediatric
Epilepsy Research, which includes the American Epilepsy Society, the
Epilepsy Foundation, the Epilepsy Therapy Project, Fight Against
Childhood Epilepsy and Seizures (F.A.C.E.S.), and Parents Against
Childhood Epilepsy (P.A.C.E.); the GE/NFL Head Health Challenge I;
the Indiana State Department of Health Spinal Cord and Brain Injury
Fund Research Grant Program; a Project Development Team within
the ICTSI NIH/NCRR Grant Number RR025761. Institute of Mental
Health, Singapore: Singapore Bioimaging Consortium (RP C-009/06)
and NMRC CSSSP (Jun17033) awarded to KS. KaSP: Swedish Medical
Research Council (SE: 2009-7053; 2013-2838; SC: 523-2014-3467);
the Swedish Brain Foundation; Svenska Läkaresällskapet; Torsten
Söderbergs Stiftelse; Söderbergs Königska Stiftelse; Knut and Alice
Wallenberg Foundation; Stockholm County Council (ALF and PPG);
KID-funding from the Karolinska Institutet. MCIC: NIH
P20GM103472; NIH R01EB020407; the Department of Energy DE-
FG02-99ER62764 through its support of the Mind Research Network
(MRN, formerly known as the MIND Institute); National Association
for Research in Schizophrenia and Affective Disorders (NARSAD)
Young Investigator Award (to SE); Blowitz-Ridgeway and Essel Foun-
dations, NWO ZonMw TOP 91211021; the DFG research fellowship
(to SE); the Mind Research Network, National Institutes of Health
through NCRR 5 month-RR001066 (MGH General Clinical Research
Center); NIMH K08 MH068540; the Biomedical Informatics Research
Network with NCRR Supplements to P41 RR14075 (MGH), M01 RR
01066 (MGH), NIBIB R01EB006841 (MRN), R01EB005846 (MRN),
2R01 EB000840 (MRN), 1RC1MH089257 (MRN); U24 RR021992.
METHCT: South African Medical Research Council. NETHERLANDS
TWIN REGISTRY (NTR): Netherlands Organization for Scientific
Research (NWO) MW904-61-193 (de Geus & Boomsma), MaGW-nr:
400-07- 080 (van't Ent), MagW 480-04-004 (Boomsma); NWO/SPI
56-464-14192 (Boomsma); the 646 European Research Council, ERC-
230374 (Boomsma); Amsterdam Neuroscience; KNAW Academy Profes-
sor Award (PAH/6635) NeuroIMAGE: National Institutes of Health
(R01MH62873 to SV Faraone); NWO Large Investment (1750102007010
to JK Buitelaar); NWO Brain & Cognition (433-09-242 to JK Buitelaar);
Radboud University Medical Center, University Medical Center Groningen,
Accare; VU University Amsterdam; the European Community's Sev-
enth Framework Programme (FP7/2007 – 2013) under grant agree-
ments n 602805 (Aggressotype), n 278948 (TACTICS), and n
602450 (IMAGEMEND); the European Community's Horizon 2020
Programme (H2020/2014 – 2020) under grant agreements n
643051 (MiND) and n 667302 (CoCA); Research Council of Norway
(#276082). Neuroventure: Canadian Institutes of Health Research
(#287378, #FRN114887, #FRN126053). New York University:
R01MH083246. Northwestern University: NIH grants P50
MH071616, R01 MH056584, R01 MH084803 (Wang PI), U01
MH097435 (Wang, Turner, Ambite, Potkin PIs), R01 EB020062
(Miller, Paulsen, Mostfosky, Wang PIs), NSF 1636893 (Pestilli, Wang,
Saykin, Sporns PIs), NSF 1734853 (Pestilli, Garyfallidis, Henschel,
Wang, Dinov PIs). NUI Galway: Health Research Board Ireland
(HRA-POR-2013-324, HRA-POR-2011-100). Older Australian Twins
Sample (OATS): NHMRC/ARC Strategic Award (ID401162); NHMRC
Program Grants (ID568969, ID1093083); NHMRC Project Grants
(ID1045325, ID1024224, ID1025243); we also thank Twins
Research Australia. Oxford University: MRC G0500092. QTIM - Uni-
versity of Queensland: National Institute of Child Health and Human
Development (R01 HD050735); National Health and Medical
Research Council (NHMRC 486682, 1009064) Australia. S~ao Paolo
1, S~ao Paolo 3: Conselho Nacional de Desenvolvimento Científico e
Tecnológico (CNPq, Brazil); Wellcome Trust, UK. SHIP: SHIP is part
of the Community Medicine Research net of the University of
Greifswald, Germany, funded by the Federal Ministry of Education
and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the
Ministry of Cultural Affairs and the Social Ministry of the Federal
State of Mecklenburg-West Pomerania. MRI scans in SHIP and
SHIP-TREND have been supported by a joint grant from Siemens
Healthineers, Erlangen, Germany and the Federal State of
Mecklenburg-West Pomerania. Stanford University: NIH Grant
R37-MH101495; NIH Grant R01 MH059259 (to IHG). STROKEMRI:
South-Eastern Norway Regional Health Authority (#2019107,
#2015044); Norwegian ExtraFoundation for Health and Rehabilita-
tion (#2015/FO5146). Sydney Memory and Aging Study (MAS):
NHMRC Program Grants (ID350833, ID568969, ID1093083). TOP:
Research Council of Norway (#223273, #248778, #249795,
#300768); South-Eastern Norway Regional Health Authority
(#2019-108, #2014097, #2019101); K.G. Jebsen Foundation (SKGJ-
MED-008); EU (847776); European Research Council Starting Grant
(#802998 to LTW); Department of Psychology, University of Oslo.
UMC Utrecht 1 (CTR): zonmw 60-6360098602. University of Bari
Aldo Moro (UNIBA): European Union Seventh Framework Pro-
gramme for research, technological development and demonstration
under grant agreement no. 602450 (IMAGEMEND) awarded to
Alessandro Bertolino; “Ricerca Finalizzata” Grant PE-2011-02347951
awarded to Alessandro Bertolino; European Union's Horizon 2020
research and innovation program under the Marie Skłodowska-Curie
Grant No. 798181 (FLOURISH) awarded to Giulio Pergola. University of
Bonn (Financial Risk Seeking Study): Frankfurt Institute for Risk
Managemand and Regulation. University of Edinburgh: Wellcome
WIERENGA ET AL. 27
Trust (104036/Z/14/Z, 216767/Z/19/Z); UKRI MRC (MC_PC_17209,
MR/S035818/1); the European Union H2020 (SEP-210574971).
University of Melbourne: National Health and Medical Research
Council of Australia (NHMRC) (#1064643, #1024570); NHMRC
Career Development Fellowships (1141738). University of Pennsylva-
nia: R01MH120482; K23MH085096; R01MH101111; MH117014;
MH119219. University of Sydney: NHMRC Research Fellowship. Yale
University: K23 MH115206; IOCDF Award. Yale University (Olin):
R01 MH106324; R01 MH096957.
COLLABORATORS
Members of the Karolinska Schizophrenia Project (KaSP) consortium:
Farde L1, Flyckt L1, Engberg G2, Erhardt S2, Fatouros-Bergman H1,
Cervenka S1, Schwieler L2, Piehl F3, Agartz I1,4,5, Collste K1, Sellgren
CM2, Victorsson P1, Malmqvist A2, Hedberg M2, Orhan F2. 1 Centre
for Psychiatry Research, Department of Clinical Neuroscience,
Karolinska Institutet, & Stockholm Health Care Services, Stockholm
County Council, Stockholm, Sweden; 2 Department of Physiology and
Pharmacology, Karolinska Institutet, Stockholm, Sweden; 3 Neu-
roimmunology Unit, Department of Clinical Neuroscience, Karolinska
Institutet, Stockholm, Sweden; 4 NORMENT, Division of Mental
Health and Addiction, Oslo University Hospital & Institute of Clinical
Medicine, University of Oslo, Oslo, Norway; 5 Department of Psychi-
atry, Diakonhjemmet Hospital, Oslo, Norway.
CONFLICT OF INTEREST
The authors declare the following competing interests: OAA: Speaker's
honorarium from Lundbeck, Consultant of HealthLyti; PA: Received pay-
ments for consultancy to Shire/Takeda, Medic, educational/research
awards from Shire/Takeda, GW Pharma, Janssen-Cila, speaker at spon-
sored events for Shire, Flynn Pharma, Medic; TB: advisory or consultancy
role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH,
Shire, and Infectopharm, conference support or speaker's fee by Lilly,
Medice, and Shire, received royalities from Hogrefe, Kohlhammer, CIP
Medien, Oxford University Press - the present work is unrelated to the
above grants and relationship; DB: serves as an unpaid scientific consul-
tant for an EU-funded neurofeedback trial that is unrelated to the
present work; HB: Advisory Board, Nutricia Australi; CRKC:
received partial research support from Biogen, Inc. (Boston, USA)
for work unrelated to the topic of this manuscript; BF: received
educational speaking fees from Medice; HJG: received travel grants
and speakers honoraria from Fresenius Medical Care, Neuraxpharm,
Servier and Janssen Cilag as well as research funding from
Fresenius Medical Care; NJ and PMT: MPI of a research related
grant from Biogen, Inc., for research unrelated to the contents of
this manuscript; JK: given talks at educational events sponsored by
Medic; all funds are received by King's College London and used for
studies of ADHD; DM-C: receives fees from UpToDate, Inc and
Elsevier, all unrelated to the current work; AMM: received research
support from Eli Lilly, Janssen, and the Sackler Foundation, and
speaker fees from Illumina and Janssen; DJS: received research
grants and/or honoraria from Lundbeck and Sun. The remaining
authors declare no competing interests.
AUTHOR CONTRIBUTIONS
LMW developed the theoretical framework and prepared the manu-
script with support from GED, PMT, EAC, SF, and CKT. LMW
designed the models and scripts, GED and SF analyzed the data. All
sites processed the imaging data and conducted quality control. GD,
DD, and SF brought together and organized the datasets. Cohort
PI/ENIGMA core: DD, IA, OAA, PA, TB, AB, DIB, SB, DB, HB, GFB,
DMC, XC, TMCA, CRKC, VPC, PJC, AC, DvE, SEF, BF, ADG, DCG,
IHG, HJG, OG, PG, REG, RCG, LdH, BJH, PJH, OAvdH, FMH, HEHP,
CH, NJ, JAJ, AJK, JK, LL, ISL, CL, NGM, DM-C, BM, BCM, CMcD,
AMM, KLM, JMM, LN, JO, PP, EP-C, MJP, JR, JLR, PGPR, MDS, PSS,
TDS, AJS, KS, AS, JWS, IES, CS-M, AJS, DJS, SIT, JNT, DJV, HW, YW,
BW, LTW, HCW, SCRW, MJW, MVZ, GIdZ, YW, PMT, EAC, SF. Image
data collection: IA, TNA, AA-E, KIA, PA, SB, RB-S, AB, AB, SB, JB, AdB,
AB, VDC, XC, FXC, TMCA, VPC, AC, FC, CGD, DvE, PF-C, EJCdG,
ADG, DCG, IHG, HJG, PG, REG, LdH, BH, BJH, SNH, IBH, OAvdH,
IBB, CAH, DJH, SH, AJH, MH, NH, FMH, CH, ACJ, EGJ, AJK, KKK, JL,
LL, LdH, ISL, CL, MWJM, BM, BCM, YW, CMcD, AMM, GM, JN, YP,
PP, GP, EP-C, JR, SS, AR, GR, JLR, PSS, RS, SS, TDS, AJS, MHS, KS,
AS, LTS, PRS, AST, JNT, AU, N, HV, LW, YW, BW, WW, JDW, LTW,
SCRW, DHW, YNY, MVZ, GCZ, EAC. Image data processing/quality
control: GED, MA, TNA, AA-E, DA, KIA, AA, NB, SB, SE, AB, JB, AdB,
RMB, VDC, EJC-R, XC, FXC, CRKC, AC, CGD, EWD, SE, DvE, JPF,
PF-C, ADG, DCG, IHG, PG, TPG, BJH, SNH, OAvdH, AJH, MH, CH,
ACJ, JJ, LK, BK, JL, ISL, PHL, MWJM, SM, IM-Z, BM, BCM, YW, GM,
DvdM, JN, RS, EJC-R, YP, JR, GR, MDS, RS, TDS, KS, AS, LTS, PRS,
SIT, AST, AU, IMV, LW, YW, WW, JDW, SCRW, KW, DHW, YNY,
CKT. Manuscript revision: GED, IA, MA, AA-E, PA, AB, HB, RMB, JKB,
VDC, EJC-R, XC, AC, CGD, DD, SE, PF-C, EJCdG, ADG, DCG, IHG,
HJG, REG, RCG, TPG, BH, BJH, CAH, OAvdH, AJH, NH, FMH, ACJ,
EGJ, JAJ, MK, JL, PHL, CL, DM-C, BM, BCM, AMM, DvdM, YP, GP,
EP-C, MJP, JR, GR, PSS, RS, AJS, KS, AS, DJS, HST, AST, JNT, AU, N,
HV, BW, LTW, KW, DHW.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on
request from the corresponding author. The data are not publicly
available due to privacy or ethical restrictions.
ORCID
Lara M Wierenga https://orcid.org/0000-0001-9362-563X
Gaelle E Doucet https://orcid.org/0000-0003-4120-0474
Rachel M Brouwer https://orcid.org/0000-0002-7466-1544
Christopher RK Ching https://orcid.org/0000-0003-2921-3408
Simon E Fisher https://orcid.org/0000-0002-3132-1996
Jean-Paul Fouche https://orcid.org/0000-0002-0830-2324
David C Glahn https://orcid.org/0000-0002-4749-6977
Tiril P Gurholt https://orcid.org/0000-0002-1272-7616
Odile A van den Heuvel https://orcid.org/0000-0002-9804-7653
Martine Hoogman https://orcid.org/0000-0002-1261-7628
Hilleke E Hulshoff Pol https://orcid.org/0000-0002-2038-5281
Knut K Kolskår https://orcid.org/0000-0003-3878-814X
Bernd Krämer https://orcid.org/0000-0002-1145-9103
28 WIERENGA ET AL.
REFERENCES
Alnæs, D., Kaufmann, T., van der Meer, D., Córdova-Palomera, A.,
Rokicki, J., Moberget, T., … Westlye, L. T. (2019). Brain heterogeneity
in schizophrenia and its association with polygenic risk. JAMA Psychia-
try, 76(7), 739.
Arden, R., & Plomin, R. (2006). Sex differences in variance of intelligence
across childhood. Personality and Individual Differences, 41, 39–48.
Arnold, A. P. (2012). The end of gonad-centric sex determination in mam-
mals. Trends in Genetics, 28(2), 55–61.
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004). Inhibition and the
right inferior frontal cortex. Trends in Cognitive Sciences, 8(4), 170–177.
Baaré, W., Pol, H., Boomsma, D. I., & Posthuma, D. (2001). Quantitative
genetic modeling of variation in human brain morphology. Cerebral
Cortex, 111(9), 816–824.
Bao, A. M., & Swaab, D. F. (2010). Sex differences in the brain, behavior,
and neuropsychiatric disorders. The Neuroscientist, 16(5), 550–565.
Baye, A., & Monseur, C. (2016). Gender differences in variability and
extreme scores in an international context. Large-scale Assessements in
Education, 4(1), 1–16.
Benjamini, Y., & Hochberg, Y. (1995). Controlling the false discovery rate:
a practical and powerful approach to multiple testing. Journal of the
Royal Statistical Society: Series B (Methodological), 57(1), 289–300.
Borkenau, P., McCrae, R. R., & Terracciano, A. (2013). Do men vary more
than women in personality? A study in 51 cultures. Journal of Research
in Personality, 47(2), 135–144.
Breiman, L. (2001). Random Forests. Machine Learning, 45, 5–32.
Burgess, N., Maguire, E. A., & O'Keefe, J. (2002). The human hippocampus
and spatial and episodic memory. Neuron, 35(4), 625–641.
Buzsáki, G., Logothetis, N., & Singer, W. (2013). Perspective. Neuron, 80(3),
751–764.
Chen, X., Watkins, R., Delot, E., Reliene, R., Schiestl, R. H., Burgoyne, P. S., &
Arnold, A. P. (2008). Sex difference in neural tube defects in P53-null
mice is caused by differences in the complement of X Not Y genes.
Developmental Neurobiology, 68(2), 265–273.
Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G., & Angold, A. (2003). Prev-
alence and development of psychiatric disorders in childhood and ado-
lescence. Archives of General Psychiatry, 60(8), 837.
Craig, I. W., Haworth, C. M. A., & Plomin, R. (2009). Commentary on ‘a role
for the x chromosome in sex differences in variability in general intelli-
gence?’ (Johnson et al., 2009). Perspectives on Psychological Science, 4
(6), 615–621.
Dale, A. M., Fischl, B., & Sereno, M. I. (1999). Cortical surface-based analy-
sis. I. Segmentation and surface reconstruction. NeuroImage, 9(2),
179–194.
Dawson, G., Ashman, S. B., & Carver, L. J. (2000). The role of early experi-
ence in shaping behavioral and brain development and its implications
for social policy. Development and Psychopathology, 12(4), 695–712.
Del Giudice, M., Lippa, R. A., Puts, D. A., Bailey, D. H., Bailey, J. M., &
Schmitt, D. P. (2016). Joel et al.'s method systematically fails to detect
large, consistent sex differences. Proceedings of the National Academy
of Sciences, 113(14), E1965.
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C.,
Blacker, D., … Kiliany, R. J. (2006). An automated labeling system for
subdividing the human cerebral cortex on MRI scans into gyral based
regions of interest. NeuroImage, 31(3), 968–980.
Dima, D., Papachristou, E., Modabbernia, A., Doucet, G. E., Agartz, I.,
Aghajani, M., … Frangou, S. (2020). Subcortical volume trajectories
across the lifespan: Data from 18,605 healthy individuals aged 3-90
years. bioRxiv.
Eyler, L. T., Prom-Wormley, E., Panizzon, M., Kaup, A. R., Fennema-
Notesine, C., Neale, M. C., … Kremen, W. S. (2011). Genetic and envi-
ronmental contributions to regional cortical surface area in humans: A
magnetic resonance imaging twin study. Cerebral Cortex, 21(10),
2313–2321.
Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., …
Dale, A. M. (2002). Whole brain segmentation: Automated labeling of
neuroanatomical structures in the human brain. Neuron, 33(3),
341–355.
Fischl, B., Sereno, M. I., Tootell, R. B., & Dale, A. M. (1999). High-resolution
intersubject averaging and a coordinate system for the cortical surface.
Human Brain Mapping, 8(4), 272–284.
Forde, N. J., Jeyachandra, J., Joseph, M., Jacobs, G. R., Dickie, E.,
Satterthwaite, T. D., … Voineskos, A. N. 2020. “Sex differences in vari-
ability of brain structure across the lifespan.” Cerebral Cortex, 30(10),
5420–5430.
Frangou, S., Modabbernia, A., Doucet, G. E., Papachristou, E.,
Williams, S. C. R., Agartz, I., & Dima, D. (2020). Cortical thickness tra-
jectories across the lifespan: Data from 17,075 healthy individuals
aged 3-90years. bioRxiv.
Goldstein, J. M., Seidman, L. J., & O'brien, L. M. (2002). Impact of normal
sexual dimorphisms on sex differences in structural brain abnormalities
in schizophrenia assessed by magnetic resonance imaging. Archives of
General Psychiatry, 59, 154–164.
Grillner, S., Hellgren, J., Ménard, A., Saitoh, K., & Wikström, M. A. (2005).
Mechanisms for selection of basic motor programs--roles for the stria-
tum and pallidum. Trends in Neurosciences, 28(7), 364–370.
Herting, M. M., Johnson, C., Mills, K. L., Vijayakumar, N., Dennison, M.,
Liu, C., … Tamnes, C. K. (2018). Development of subcortical volumes
across adolescence in males and females: A multisample study of lon-
gitudinal changes. NeuroImage, 172, 194–205.
Hyde, J. S. (2014). Gender similarities and differences. Annual Review of
Psychology, 65, 373–398.
Jahanshad, N., & Thompson, P. M. (2016). Multimodal neuroimaging of
male and female brain structure in health and disease across the life
span. Journal of Neuroscience Research, 95(1-2), 371–379.
Joel, D., & Fausto-Sterling, A. (2016). Beyond sex differences: New
approaches for thinking about variation in brain structure and func-
tion. Philosophical Transactions of the Royal Society B: Biological Sci-
ences, 371(1688), 20150451.
Joel, D., Berman, Z., Tavor, I., Wexler, N., Gaber, O., Stein, Y., … Assaf, Y.
(2015). Sex beyond the genitalia: The human brain mosaic. Proceedings
of the National Academy of Sciences, 112(50), 15468–15473.
Johnson, W., Carothers, A., & Deary, I. J. (2008). Sex differences in variabil-
ity in general intelligence: A new look at the old question. Perspectives
on Psychological Science.3(6), 518–531.
Johnson, W., Carothers, A., & Deary, I. J. (2009). A role for the X chromo-
some in sex differences in variability in general intelligence? Perspec-
tives on Psychological Science, 4(6), 598–611.
Katzman, S., & Alliger, G. M. (1992). Averaging untransformed variance ratios
can be misleading. Review of Educational Research, 62(4), 427–428.
Koolschijn, P. C. M. P., & Crone, E. A. (2013). Sex differences and structural
brain maturation from childhood to early adulthood. Developmental
Cognitive Neuroscience, 5, 106–118.
Kremen, W. S., Fennema-Notestine, C., Eyler, L. T., Panizzon, M. S.,
Chen, C. H., Franz, C. E., … Dale, A. M. (2013). Genetics of brain struc-
ture: Contributions from the Vietnam era twin study of aging. Ameri-
can Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 162B
(7), 751–761.
Lehre, A.-C., Lehre, K. P., Laake, P., & Danbolt, N. C. (2009). Greater intra-
sex phenotype variability in males than in females is a fundamental
aspect of the gender differences in humans. Developmental Psychobiol-
ogy, 51(2), 198–206.
Lerch, J. P., Worsley, K., Shaw, W. P., Greenstein, D. K., Lenroot, R. K.,
Giedd, J., … Evans, A. C. (2006). Mapping anatomical correlations
across cerebral cortex (macacc) using cortical thickness from MRI.
NeuroImage, 31(3), 993–1003.
Marwha, D., Halari, M., & Eliot, L. (2017). Meta-analysis reveals a lack of sexual
dimorphism in human amygdala volume. NeuroImage, 147(C), 282–294.
WIERENGA ET AL. 29
Meinshausen, N. (2006). Quantile regression forests. Journal of Machine
Learning Research, 7, 983–999.
Mowinckel, A. M., & Vidal-Piñeiro, D. (2019). Visualisation of brain statis-
tics with r-packages Ggseg and Ggseg3d. arXiv, 1912.08200, 1–17.
Northoff, G., & Tumati, S. (2019). ‘Average is good, extremes are bad’ -
non-linear inverted u-shaped relationship between neural mechanisms
and functionality of mental features. Neuroscience & Biobehavioral
Reviews, 104, 11–25.
Pardoe, H. R., Kucharsky Hiess, R., & Kuzniecky, R. (2016). Motion and
morphometry in clinical and nonclinical populations. NeuroImage, 135,
177–185.
Pfefferbaum, A., Sullivan, E. V., & Carmelli, D. (2004). Morphological
changes in aging brain structures are differentially affected by time-
linked environmental influences despite strong genetic stability. Neuro-
biology of Aging, 25(2), 175–183.
Pomponio, R., Erus, G., Habes, M., Doshi, J., Srinivasan, D., Mamourian, E., …
Davatzikos, C. (2020). Harmonization of large MRI datasets for the
analysis of brain imaging patterns throughout the lifespan. NeuroImage,
208, 116450.
Reinhold, K., & Engqvist, L. (2013). The variability is in the sex chromo-
somes. Evolution: International Journal of Organic Evolution, 67(12),
3662–3668.
Reuter, M., Tisdall, M. D., Qureshi, A., Buckner, R. L., van der
Kouwe, A. J. W., … Fischl, B. (2015). Head motion during MRI acquisi-
tion reduces gray matter volume and thickness estimates. NeuroImage,
107, 107–115.
Ritchie, S. J., Cox, S. R., Shen, X., Lombardo, M. V., Reus, L. M., Alloza, C., …
Deary, I. J. (2018). Sex differences in the adult human brain: evidence
from 5216 UK Biobank participants. Cerebral Cortex, 28(8),
2959–2975.
Roalf, D. R., Gur, R. E., Ruparel, K., Calkins, M. E., Satterthwaite, T. D.,
Bilker, W. B., … Gur, R. C. (2014). Within-individual variability in
neurocognitive performance: age- and sex-related differences in chil-
dren and youths from ages 8 to 21. Neuropsychology, 28(4), 506–518.
Rousselet, G. A., C. R. Pernet, & R. R. Wilcox. 2017. “Beyond differences in
means: robust graphical methods to compare two groups in neurosci-
ence.” European Journal of Neuroscience 121079.46(2), 1738–1748.
Ruigrok, A. N. V., Salimi-Khorshidi, G., Lai, M. C., Baron-Cohen, S.,
Lombardo, M. V., Tait, R. J., … Suckling, J. (2014). A meta-analysis of
sex differences in human brain structure. Neuroscience & Biobehavioral
Reviews, 39, 34–50.
Ryan, S. G., Chance, P. F., Zou, C. H., Spinner, N. B., Golden, J. A., …
Smietana, S. (1997). Epilepsy and mental retardation limited to
females: An X-linked dominant disorder with male sparing. Nature
Genetics, 17(1), 92–95.
Stevens, C. F. (1989). How cortical interconnectedness varies with net-
work size. Neural Computation, 1(4), 473–479.
Tamnes, C. K., Herting, M. M., Goddings, A.-L., Meuwese, R., Blakemore, S.-J.,
Dahl, R. E., … Mills, K. L. (2017). “Development of the cerebral cortex
across adolescence: A multisample study of interrelated longitudinal
changes in cortical volume, surface area and thickness..” Journal of Neuro-
science, 37(12), 3402–3412.
Tan, A., W. Ma, A. Vira, D. Marwha, & L. Eliot. (2016). “The human hippo-
campus is not sexually-dimorphic: Meta-analysis of structural MRI
volumes.” NeuroImage 124(Part A):350–66.
van Erp, T. G. M., Walton, E., Hibar, D. P., Schmaal, L., Jiang, W., …
Turner, J. A. (2019). Reply to: new meta- and mega-analyses of mag-
netic resonance imaging findings in schizophrenia: do they really
increase our knowledge about the nature of the disease process?.
Biological Psychiatry, 85(7), e35–e39.
Wierenga, L. M., Sexton, J. A., Laake, P., Giedd, J. N., Tamnes, C. K., &
Pediatric Imaging, Neurocognition, and Genetics Study (2018). A key
characteristic of sex differences in the developing brain: greater vari-
ability in brain structure of boys than girls. Cerebral Cortex, 28(8),
2741–2751.
Wierenga, L. M., Bos, M. G. N., Schreuders, E., Vd Kamp, F., Peper, J. S.,
Tamnes, C. K., & Crone, E. A. (2018). Unraveling age, puberty and tes-
tosterone effects on subcortical brain development across adoles-
cence. Psychoneuroendocrinology, 91, 105–114.
Wierenga, L. M., Bos, M. G. N., van Rossenberg, F., & Crone, E. A. (2019).
Sex effects on development of brain structure and executive func-
tions: greater variance than mean effects. Journal of Cognitive Neurosci-
ence, 31(5), 730–753.
Wu, H., Luo, J., Yu, H., Rattner, A., Mo, A., Wang, Y., … Nathans, J. (2014).
Cellular resolution maps of X chromosome inactivation: Implications
for neural development, function, and disease. Neuron, 81(1),
103–119.
Zabihi, M., Oldehinkel, M., Wolfers, T., Frouin, V., Goyard, D., Loth, E., …
Marquand, A. F. (2019). Dissecting the heterogeneous cortical anat-
omy of autism spectrum disorder using normative models. Biological
Psychiatry. Cognitive Neuroscience and Neuroimaging, 4(6), 567–578.
SUPPORTING INFORMATION
Additional supporting information may be found online in the
Supporting Information section at the end of this article.
How to cite this article: Wierenga LM, Doucet GE, Dima D,
et al. Greater male than female variability in regional brain
structure across the lifespan. Hum Brain Mapp. 2020;1–30.
https://doi.org/10.1002/hbm.25204
30 WIERENGA ET AL.
